Article Details

Catalio Capital Joins $93 Million Series B for Character Biosciences | citybiz

Retrieved on: 2025-03-31 06:01:50

Tags for this article:

Click the tags to see associated articles and topics

Catalio Capital Joins $93 Million Series B for Character Biosciences | citybiz. View article details on hiswai:

Summary

The article details Character Biosciences' public relations efforts to announce a $93 million Series B funding round, involving entities like Catalio Capital Management and Bausch & Lomb, with ties to Baltimore, Johns Hopkins School of Medicine, and partnerships in precision medicine advancements.

Article found on: www.citybiz.co

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up